The distinction between forms of sinus tachycardia and other atrial tachycardias is, however, important for correct treatment. Although no specific symptoms are associated with NST, patients with ...

Tom Nolan reviews this week’s research There’s certainly a gap in the market for an effective third or fourth line antihypertensive. A trial of lorundrostat, an aldosterone synthase inhibitor, found a ...

In the end, there’s no one-size-fits-all solution for treating arrhythmia. The best medication for an irregular heartbeat ...

episodes classified as atrial tachycardia. The AF Suppression Algorithm reduced symptomatic AF burden from 2.50% in the control group to 1.87% in the treatment group, a relative difference of 25%.

The therapy has made a major impact in the treatment of atrial fibrillation ... of patients showing freedom from afib, flutter and atrial tachycardia. Additionally, 81% showed no afib recurrence ...

The study found that women have genes that help their hearts beat faster while men have gene networks that may lead to heart ...

The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...

The multidisciplinary care required to treat these complex patients is most often found in higher-volume centers.

Field Medical is developing transformative technology for the treatment of all cardiac ... Prevalence of VT and AF Ventricular tachycardia (VT) and atrial fibrillation (AF) are two of the most ...

The funding will support the completion of two pilot studies – VCAS for VT and Field PULSE for atrial fibrillation ... transformative technology for the treatment of all cardiac arrhythmias ...

Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on ...